Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Histo-Blood Group Antigen Null Phenotypes Associated With a Decreased Risk of Clinical Rotavirus Vaccine Failure Among Children <2 Years of Age Participating in the Vaccine Impact on Diarrhea in Africa (VIDA) Study in Kenya, Mali, and the Gambia

Clinical Infectious Diseases(2023)10.1093/cid/ciac910Source: DataRank Database

Histo-Blood Group Antigen Null Phenotypes Associated With a Decreased Risk of Clinical Rotavirus Vaccine Failure Among Children <2 Years of Age Participating in the Vaccine Impact on Diarrhea in Africa (VIDA) Study in Kenya, Mali, and the Gambia is a research paper published in Clinical Infectious Diseases (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.53)OA: hybridTopics (67)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (33)

Jennifer Oshinsky ORCID,Mardi Reymann,Mathew D. Esona ORCID,Michael D. Bowen ORCID,M Jahangir Hossain ORCID

Live enrichment

PubMed:37074435 PMC:PMC10116560 OpenAlex:https://openalex.org/W4366350995

NIAID NIH HHS

Grant: F31 AI126629

NIAID NIH HHS

Grant: R37 AI032042

National Institutes of Health

Grant: 5F31AI126629-02

Genetically determined susceptibility to rotavirus and rotavirus vaccine failure in sub-Saharan Africa

National Institutes of Health

Grant: 5R37AI032042-19

Methods for Evaluating Vaccine Efficacy

National Institutes of Health

Bill & Melinda Gates Foundation

FWCI

0.53

Citation Percentile

0.6%

Citation Trend

2023

2026

hybridLicense: cc-by

journalhttps://academic.oup.com/cid/article-pdf/76/Supplement_1/S153/50031621/ciac910.pdf

publisherhttps://academic.oup.com/cid/article-pdf/76/Supplement_1/S153/50031621/ciac910.pdf

journalhttp://dx.doi.org/10.1093/cid/ciac910

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37074435

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10116560

Fields of Study

Viral gastroenteritis research and epidemiologyInfant Nutrition and HealthListeria monocytogenes in Food Safety03 medical and health sciences0303 health sciencesHumansBlood Group AntigensRotavirus VaccinesRotavirus InfectionsGambiaKenyaMaliDiarrheaRotavirusPhenotype

MeSH Terms

Blood Group AntigensDiarrheaGambiaHumansKenyaMaliPhenotypeRotavirus InfectionsRotavirusRotavirus Vaccines

Keywords

RotavirusRotavirus vaccineDiarrheaMedicineOdds ratioConfidence intervalImmunologyGenotypeVirologyPopulationVaccinationVaccine failureInternal medicineBiologyGeneticsHost GeneticsHbga PhenotypeRotavirus Vaccine FailureFOS: Health sciencesMaliGeneRotavirus InfectionsAgricultural and Biological SciencesHealth SciencesHumansHepatitis E Infection and TreatmentViral Diseases in Livestock and PoultryHepatologyVIDA SupplementFOS: Clinical medicineRotavirus VaccinesGastrointestinal Viral Infections and Vaccines DevelopmentLife SciencesKenyaPhenotypeInfectious DiseasesEnvironmental healthFOS: Biological sciencesBlood Group AntigensGambiaAnimal Science and ZoologyMeasles

Sustainable Development Goals

SDG 0: No poverty